advertisement

---

Bilgic A 9

Showing records 1 to 9 | Display all abstracts from Bilgic A

85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Bilgic A
Journal of Ophthalmology 2020; 2020: 7462098

---

85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Bilgic A; Sudhalkar A
Journal of Ophthalmology 2020; 2020: 8359398

---

85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Kodjikian L; Chhablani J
Journal of Ophthalmology 2020; 2020: 7462098

---

85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Trivedi M; Trivedi M
Journal of Ophthalmology 2020; 2020: 8359398

---

85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Trivedi M; Trivedi M; Vasavada V
Journal of Ophthalmology 2020; 2020: 7462098

---

85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Vasavada S; Vasavada S; Vasavada V
Journal of Ophthalmology 2020; 2020: 8359398

---

85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Vasavada S
Journal of Ophthalmology 2020; 2020: 7462098

---

85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Srivastava S
Journal of Ophthalmology 2020; 2020: 8359398

---

85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Vasavada S; Srivastava S; Bhojwani D; Sudhalkar A
Journal of Ophthalmology 2020; 2020: 7462098

---